Vascular Biogenics Profile

2.10
USD 0.03  1.18%
0%
100%

Vascular Biogenics Summary

Vascular Biogenics Ltd (VBLT) is traded on NASDAQ General Markets in USA. It is located in 8 HaSatat Street and employs 37 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 76.19 M. Vascular Biogenics Ltd conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 35.86 M outstanding shares of which 457.96 K shares are at this time shorted by private and institutional investors with about 1.14 trading days to cover. Vascular Biogenic currently holds about 49.89 M in cash with (1.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.67.
Check Vascular Biogenics Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 2.1HorizonTargetOdds Above 2.1
22.43%30 days 2.10 77.45%
Based on normal probability distribution, the odds of Vascular Biogenics to move above current price in 30 days from now is about 77.45% (This Vascular Biogenics Ltd probability density function shows the probability of Vascular Biogenics Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Creative PlanningCommon Shares22.1 K49 K
Steward Partners Investment Advisory LlcCommon Shares1.2 K3 K
Dld Asset Management LpCall Options244.5 K555 K
Group One Trading LpPut Options108.2 K249 K
View Vascular Biogenics Diagnostics

Vascular Biogenics Risk Profiles

Key Fundamentals

Vascular Biogenics Against Markets

Current Ratings

Vascular Biogenics 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
89 
Equity ratings for Vascular Biogenics Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for cancer. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Modiin, Israel. Vascular Biogenics operates under Biotechnology classification in USA and traded on NASDAQ General Markets. It employs 37 people. more
NameVascular Biogenics Ltd
CEO, DirectorDror HaratsView All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business Address8 HaSatat Street
ExchangeNASDAQ General Markets
SectorHealthcare
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.vblrx.com
Phone972 8 993 5000
CurrencyUSD - US Dollar

Vascular Biogenics Corporate Directors

Philip Serlin Non-Executive Independent Director
Dan Gelvan Non-Executive Independent Director
Ron Cohen Non-Executive Independent Director
Also please take a look at World Market Map. Please also try Portfolio Quick Import module to import or update all your transactions via one easy-to-use interface.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">